Effect of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy on the Risk of Arterial Thromboembolic Events: A Meta-Analysis

BACKGROUND: Intravitreal anti-vascular endothelial growth factor (VEGF) monoclonal antibodies are used in ocular neovascular diseases. A consensus has emerged that intravenous anti-VEGF can increase the risk of arterial thromboembolic events. However, the role of intravitreal anti-VEGF in arterial t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Jin-Wei, Cheng, Shi-Wei, Lu, Guo-Cai, Wei, Rui-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400599/
https://www.ncbi.nlm.nih.gov/pubmed/22829940
http://dx.doi.org/10.1371/journal.pone.0041325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400599/
https://www.ncbi.nlm.nih.gov/pubmed/22829940
http://dx.doi.org/10.1371/journal.pone.0041325

Ejemplares similares